Tetrabenazine

CAS 58-46-8 10 API suppliersSmall Molecule

Overview

Tetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor used to treat hyperkinetic movement disorders such as Huntington's disease. It reduces the excess dopamine activity in the brain that contributes to these disorders.

API suppliers (10)

Suppliers of Tetrabenazine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India6Spain2China1France1

6 of 10 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

NeurologyMovement Disorders
Verified Supplier Partner

Do you supply Tetrabenazine? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.